Roche’s Tecentriq combo scoops up European approval in first-line metastatic lung cancer
March 8, 2019Medical Communications, Sales and Marketing Cancer, Europe, European Commission, NSCLC, Roche, lung cancer, pharma
Roche has announced the approval of the European Commission for its PD-L1 inhibitor Tecentriq (atezolizumab) when used in combination with …
Dutch pharmacists to circumvent Novartis cancer drug market exclusivity
March 8, 2019Medical Communications Bruno Bairns, Cancer, Luathera, Novartis, aaa
Dutch pharmacists have vowed to circumvent rules enforcing Novartis’ market exclusivity for radioactive cancer drug Lutathera. Pharmacists at Erasmus, …
Glenmark spinoff name Gilead VP Alessandro Riva as new CEO
March 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Gilead’s Dr Alessandro Riva, is stepping down from his position as the company’s Executive Vice President, Oncology Therapeutics to head …
Gilead’s Biktarvy maintains HIV suppression for 48 weeks in children and adolescents
March 7, 2019Research and Development Biktarvy, Gilead, HIV, pharma
Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 …
Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea
March 7, 2019Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries
A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …
Allergan’s depression drug rapastinel fails to outperform placebo at Phase 3
March 7, 2019Research and Development Allergan, FDA, depression, major depressive disorder, pharma, rapastinel
As Janssen celebrated the FDA approval of the first novel therapy for depression in three decades with Spravato, Allergan released …
Public satisfaction with NHS falls to lowest point since 2007
March 7, 2019Medical Communications England, King's, NHS, Nuffield, Scotland, UK, Wales, kings, public stisfaction
Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social …
Médecins Sans Frontières (MSF)/ Doctors Without Borders calls on CEPI to revise ‘toothless’ access policy
March 6, 2019Sales and Marketing CEPI, MSF, access, public health, tokyo, vaccines
The humanitarian organisation Médecins Sans Frontières (MSF) has called on The Coalition for Epidemic Preparedness Innovations (CEPI) to revise their …
FDA Commissioner Scott Gottlieb announces resignation
March 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
Indian measles vaccination campaign saved tens of thousands of lives
March 6, 2019Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines
A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …
Janssen’s party drug-based nasal spray becomes first new FDA-approved depression treatment in 30 years
March 6, 2019Research and Development, Sales and Marketing Janssen, Spravato, depression, esketamine, pharma
The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s …
Postoperative radiation can triple survival in children with brain cancer
March 6, 2019Research and Development brain cancer, children, epndymoma, oncology, paediatric brain cancer, radiation
Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …
Women scientists receive $41,000 less in funding than men, study shows
March 6, 2019Research and Development NIH, funding, international womens day, management, science, women
Women scientists receive $41,000 less in federal funding than men, according to a study of nearly 54,000 grants to first …
Sunovion CMO Dr Antony Loebel made company’s new CEO
March 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion
Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …
Akcea and Ionis’ Waylivra nets CHMP approval in ultra-rare familial chylomicronaemia syndrome
March 5, 2019Manufacturing and Production, Sales and Marketing Akcea, FCS, Ionis, familial chylomicronemia syndrome, pharma, rare disease
Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra (volanesorsen) has been recommended by the EMA’s Committee …
Novartis set to offer 14 weeks paternity leave
March 5, 2019Manufacturing and Production Novartis, company culture, paternity leave, work
Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …
London man becomes second in world to be cured of HIV
March 5, 2019Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient
A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …
Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial
March 5, 2019Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis
New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …
OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say
March 4, 2019Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials
OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …
The cutting edge of cancer research
March 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology
While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
